James O Armitage is Director of Cardiff Oncology, Inc.. Currently has a direct ownership of 14,490 shares of CRDF, which is worth approximately $39,267. The most recent transaction as insider was on Mar 19, 2021, when has been sold 4,000 shares (Common Stock) at a price of $10.82 per share, resulting in proceeds of $43,280. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.5K
0% 3M change
0% 12M change
Total Value Held $39,267

James O Armitage Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 19 2021
BUY
Open market or private purchase
$43,280 $10.82 p/Share
4,000 Added 21.63%
14,490 Common Stock
JOA

James O Armitage

Director
San Diego, CA

Track Institutional and Insider Activities on CRDF

Follow Cardiff Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRDF shares.

Notify only if

Insider Trading

Get notified when an Cardiff Oncology, Inc. insider buys or sells CRDF shares.

Notify only if

News

Receive news related to Cardiff Oncology, Inc.

Track Activities on CRDF